Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
July 19th, 2019
•The current protocol describes methods to establish patient-derived xenograft (PDX) models and primary cancer cell lines from surgical gastric cancer samples. The methods provide a useful tool for drug development and cancer biology research.
Related Videos
Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment
A Melanoma Patient-Derived Xenograft Model
Isolation and Characterization of Patient-derived Pancreatic Ductal Adenocarcinoma Organoid Models
Drug Screening of Primary Patient Derived Tumor Xenografts in Zebrafish
The Establishment and Utilization of Patient Derived Xenograft Models of Central Nervous System Metastasis
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
